Schedule 13G ownership disclosure

Soleno Therapeutics Inc

Common Stock, $0.001 par value · CUSIP: 834203309

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nantahala Capital Management, LLC

    Shares: 2,627,651.00 · Class: 5.6%

  • Wilmot B. Harkey

    Shares: 2,627,651.00 · Class: 5.6%

  • Daniel Mack

    Shares: 2,627,651.00 · Class: 5.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-042671
Form type
SCHEDULE 13G/A
Filer
Nantahala Capital Management, LLC
CIK
CIK 1472322
Filed
Apr 30, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub